Latest News
Can a Night in a Laboratory Improve Sleep Quality?
Robby WestReporting from University of East Anglia BBC reporter Robby West spent the night at the University of East Anglia's Sleep and Brain Research Unit Do you get enough sleep? As a new parent… [+6654 chars]
Patient's Frustration with Therapist's Time Management Sparks Concern
"And it went like that: she'd log on, flustered, and ask why I was late. It was pretty obvious from her tone, body language, and how defensive she was that she knew she was screwing up and just didn'… [+314 chars]
Mesoblast Expands Coverage for Groundbreaking Therapy Ryoncil to 104 Million Lives in the U.S.
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has continued to expand coverage for Ryoncil® (remestemcel-L), the first mesenchymal stromal cell (MSC) therapy approved by U.S. Food and Drug Administration (FDA) for any indication, to 104 million US lives insured by government and commercial payers.
Arkansas Becomes First State to Ban Pharmacy Benefit Managers from Owning Pharmacies
Arkansas has enacted a law making it the first state banning pharmacy benefit managers from owning a pharmacy in the state. Gov.
Climate Change Poses Threat to Global Blood Supply, New Study Reveals
Extreme weather disasters, increasing as the planet warms, can curb blood donations while increasing demand, a new analysis found.
World Health Organization Reaches Agreement on Pandemic Treaty After Prolonged Negotiations
The World Health Organization finally reached a compromise on a pandemic treaty after three years of talks. The United States withdrew from negotiations after President Trump took office.
Federal Experts Recommend Expansion of RSV Vaccinations and New Meningitis Shot
A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis
Annexon, Inc. Grants Inducement Award to New Non-Executive Employee
BRISBANE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that it has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award Plan. The equity award was approved on April 11, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4).
Elicio Therapeutics Secures New Talent with Inducement Awards
BOSTON, April 16, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that on April 15, 2025, Elicio granted inducement awards to Elicio’s newly appointed Chief Strategy and Financial Officer, Preetam Shah, and two additional new employees, as an inducement material to Dr. Shah and such employees entering into employment with Elicio in accordance with Nasdaq Listing Rule 5635(c)(4), which grants were approved by the compensation committee of Elicio’s board of directors in accordance with the Elicio 2024 Inducement Incentive Award Plan.
The Giorgio Foundation and University of Pittsburgh Establish $2 Million Endowed Chair to Advance NF1 Research
PITTSBURGH, April 16, 2025 /PRNewswire/ -- The Giorgio Foundation and the University of Pittsburgh announce the establishment of The Giorgio Foundation Endowed Chair in the School of Medicine's Department of Neurosurgery with a total commitment of $2 million. This gift will support...
Boost Your Kidney Health with These 13 Superfoods
It's common knowledge that you can live a fulfilling life with just one kidney, but are you aware of what your kidneys actually do? The US Centers for Disease Control and Prevention estimate that ove… [+5659 chars]
Scilex Holding Company Receives FDA Approval for Gloperba as First Liquid Colchicine for Gout and Pericarditis Treatment
PALO ALTO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that FDA has approved our request for the Orphan drug designation for colchicine for the treatment of pericarditis.
Valneva to Showcase Innovations at the 25th World Vaccine Congress in Washington, D.C.
Saint-Herblain (France), le 16 avril 2025 - Valneva SE (Nasdaq : VALN; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui sa présence au 25ème World Vaccine Congress, qui se tiendra du 21 au 24 avril 2025 au Walter E. Convention Center à Washington, D.C. Sous la direction du directeur général de la Société, Thomas Lingelbach, des membres de l’équipe dirigeante de Valneva participeront à de nombreux événements, dont une présentation sur le vaccin IXCHIQ®, premier vaccin homologué au monde contre le chikungunya.
Valneva SE to Showcase Innovations at 25th World Vaccine Congress in Washington, D.C.
Saint-Herblain (France), April 16, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E. convention center in Washington, D.C. Under the leadership of the Company´s Chief Executive Officer, Thomas Lingelbach, a team of Valneva´s senior managers will participate in multiple events, including an important presentation on the Company´s vaccine IXCHIQ®, the world’s first licensed chikungunya vaccine.
Webinar Series to Address Airborne Toxins and Rising Rates of Immune-Related Illnesses
Healthcare providers and wellness advocates are invited to explore how airborne toxins may be triggering the rising rates of immune-related illness BUFFALO, N.Y., April 16, 2025 /PRNewswire/ -- Millions of people are living with chronic infections, autoimmune diseases, and persistent...
Henlius Unveils Comprehensive ESG Report for 2024, Showcasing Commitment to Health, Environment, and Community
SHANGHAI, April 16, 2025 /PRNewswire/ -- On April 15, 2025, Henlius (2696.HK) released the "2024 Environmental, Social, and Governance (ESG) Report" (hereinafter referred to as the "ESG Report" or "Report"). This marks the sixth consecutive year that the company has submitted an...
Spain Enforces New Healthy Eating Regulations in Schools
Rules brought in this week limit amounts of fatty and fried food and levels of sugar and caffeine in drinksAll schools in Spain will be legally obliged to serve fruit and vegetables as part of their lunches and fish at least once a week under new rules aimed at reducing the amount of fried and fatty food served to children.Hailed by the government as a key plank of the fight against childhood obesity, the rules brought in by royal decree this week will also compel schools to offer vegetarian and vegan meals. Continue reading...
Federal Crackdown on Cheaper Weight-Loss Drugs Could Cut Access for Hundreds of Thousands
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
Rodent Nests Discovered Near Residence of Late Actor Gene Hackman and His Wife
Nests and some dead rodents were found in outbuildings of the house where Oscar-winning actor Gene Hackman and his wife Betsy Arakawa were found dead. New Mexico Department of Public Health records… [+2335 chars]
Sonnet BioTherapeutics Announces Positive Safety Data for SON-1010 in Advanced Cancer Treatment
- Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010
Clinton Health Access Initiative Partners with OneSight EssilorLuxottica Foundation to Enhance Vision Care in Africa
Clinton Health Access Initiative and OneSight EssilorLuxottica Foundation Launch Strategic Partnership to Expand Vision Care Access Across Africa
GRI Bio, Inc. to Present Groundbreaking Research at 2025 ATS International Conference
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that its abstract has been selected for poster presentation in a poster discussion session at the 2025 ATS International Conference being held May 18-21, 2025 in San Francisco, CA.Details of the presentation are as follows:Title: Inactivation of iNKT Cells After the Inflammatory Phase Leads to Significant Inhibition of Fibroblast Activation and Fibrosis in a Model of Pulmonary FibrosisPoster Board Number: 810Presenter: Marc Hertz, PhD, Chief Executive Officer of GRI BioSession: D21 - IMMUNOLOGICAL INSIGHTS IN LUNG INFLAMMATION AND REPAIRDate and Time: Wednesday, May 21, 2025 from 8:15-10:15 AM PTLocation: Room 2022/2024 (West Building, Level 2), Moscone CenterFor more information about the 2025 ATS International Conference, please visit the conference website, here.
Precigen and RRPF Collaborate for RRP Awareness Day 2025
– International event will raise awareness and bring together RRP patients, caregivers, and the healthcare community supporting them – – Recurrent respiratory papillomatosis is a rare, debilitating, chronic disease that impacts both children and adults and is mainly driven by HPV 6/11...
World-Renowned Surgeons Gather In NYC to Usher in A New Era Of Facial Rejuvenation with Kassir Plastic Surgeon's 2025 Master Course
World-Renowned Surgeons Gather In NYC to Usher in A New Era Of Facial Rejuvenation with Kassir Plastic Surgeries 2025 Master Course NEW YORK, April 16, 2025 /PRNewswire/ -- April 24–27, 2025 — This spring, New York City will once again set the stage for a transformative moment in beauty,...
YMCA of Frederick County Achieves Praesidium Accreditation for Excellence in Abuse Prevention
FREDERICK, Md., April 16, 2025 /PRNewswire/ -- The YMCA of Frederick County was recently awarded Praesidium Accreditation® by Praesidium, the leader in abuse risk management. This prestigious honor publicly demonstrates the YMCA of Frederick County's efforts to achieve the highest...
BriaCell's Bria-IMT Outperforms Standard Treatments in Metastatic Breast Cancer Trials
PHILADELPHIA and VANCOUVER, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces new positive survival data in its Phase 2 study of Bria-IMT plus check point inhibitors (CPI), outperforming ADC drugs in hormone receptor positive (HR+) metastatic breast cancer (MBC) patients.
King's Food Bank Faces Staffing Cuts Amid Rising Demand
The food bank in Darlington says it can no longer afford to pay four out of five of its staff.
EU Warns of Rising Unsafe Products, Primarily from China
Bloc registers steep rise in products purchased online not meeting safety standards
Mastering the Art of Squats: Techniques, Benefits, and Variations
Odds are that you've done a squat or two before, as they're a common exercise you likely learned in gym class. However, do you know the proper form for a squat and what muscles it works? Ensuring you… [+7558 chars]
Recordati Secures FDA Approval for Expanded Use of ISTURISA in Treating Cushings Syndrome
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME
Insights from a Life Coaching Expert: Seth T. Hall
This article was reviewed by Seth Hall and by wikiHow staff writer, Bailey Cho. Seth T. Hall (ICF ACC, CLC, and MNLP) is a Certified Life Coach and Founder of Transformational Solutions, a Los Angele… [+1069 chars]
Exploring Gut Health: Understanding the Microbiome and How to Nurture It
Gut health has recently been a trending topic on social media, yet it's not new. Whether or not you hopped on the bandwagon and began drinking prebiotic or probiotic beverages, many people have becom… [+6704 chars]
Living Hell for 'Forgotten' Skin Patients: The Struggles of Eczema Sufferers
Amy GladwellBBC South West Investigations Team Elle Jones, 19, says she lost periods of her teens to eczema "It's taken a big toll on my life," says Elle Jones, 19, reflecting on her severe eczema.… [+8002 chars]
Pressure on Vets to Generate Revenue Raises Concerns Over Animal Welfare
Jim Booth, Datshiane Navanayagam & Tom Wall Vet company IVC told us animal health and welfare was always its first priority Some vets are being put under "consistent pressure" to generate incom… [+7995 chars]
Easy Ways to Save Water and Money in Your Home
With household water bills in England and Wales rising by an average of 26% this year, here are the best ways to saveIf you live in England or Wales, your home has more bedrooms than people and you are not already metered, then switching to a water meter could save you hundreds of pounds each year. Continue reading...
Basilea Pharmaceutica Shines at ESCMID Global 2025 with Promising Data on Fosmanogepix
Allschwil, Switzerland, April 16, 2025
Santhera Pharmaceuticals Makes Significant Progress with AGAMREE for Duchenne Muscular Dystrophy Treatment
Pratteln, Schweiz, 16. April 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt den neuesten Fortschritt beim kommerziellen Rollout von AGAMREE® zur Behandlung von Duchenne-Muskeldystrophie (DMD) bekannt.